THE PREDICTIVE VALUE OF ANTI MULLERIAN HORMONE IN INTRAUTERINE INSEMINATION CYCLES
Fertility and Sterility(2022)
摘要
Many patients with ovulatory dysfunction or unexplained infertility proceed with intrauterine insemination (IUI) as first line fertility treatment. Ovarian reserve, especially as predicted by anti mullerian hormone (AMH), is often assessed at initial consultation, and the result used to help determine the treatment plan. While AMH has been well demonstrated to be a predictor of ovarian responsiveness to gonadotropins, it has not been validated as an independent marker of natural fertility or for outcomes in IUI cycles in the infertile population. Thus, our study investigated whether AMH levels are associated with ongoing pregnancy or clinical pregnancy loss in patients undergoing IUI cycles.
更多查看译文
关键词
intrauterine insemination cycles,mullerian hormone
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要